信息Resumption of Operations of Chloroprene Rubber Production Facility after Pipe Burst Accident at Omi Plant
信息Interim Report on the Investigation of the Chloroprene Monomer Production Equipment Accident (Japanese)
信息Publication of Interim Report of the Pipe Burst Accident at Omi Plant
信息Denka Selected as a "Most Liked!" IR Award Winner in the 2023 IR Award
IR信息FY2023 Second Quarter Financial Results Presentation Summary of Q&A Session
IR信息FY2023 Second Quarter Financial Results Presentation Materials
IR信息FY2023 Second Quarter Summary of Consolidated Financial Statements
信息Temporary Suspension of ISO 9001 Certification at an Equity-Method Affiliate of Denka
信息VLPT Japan, Biken Foundation, Denka sign agreement to develop self-amplifying "replicon" RNA influenza vaccine
信息Notice of Formulation of a Human Rights Policy of the Denka Group
IR信息FY2023 First Quarter Financial Results Presentation Summary of Q&A Session
IR信息FY2023 First Quarter Financial Results Presentation Materials
IR信息FY2023 First Quarter Summary of Consolidated Financial Statements
信息Formation of Accident Investigative Committee Concerning the Pipe Burst Accident at Omi Plant
信息Notice Concerning an Accident at Omi Plant
信息Improprieties Related to Third-Party Certification of Resin Products of Denka and an Equity-Method Affiliate, etc., and Establishment of an External Investigation Committee Consisting of Outside Experts
IR信息Notice of Convocation of the 164th Ordinary General Meeting of Shareholders Other Matters Subject to the Electronic Provision
IR信息Notice of Convocation of the 164th Ordinary General Meeting of Shareholders
IR信息FY2022 Financial Results Presentation Summary of Q&A Session
IR信息FY2022 Financial Results Presentation Topics (Launch of Mission 2030 Management Plan and Growth Strategy for Silicon Nitride and G47Δ, Oncolytic Herpes Virus)
IR信息FY2022 Financial Results Presentation Materials
IR信息FY2022 Summary of Consolidated Financial Statements
信息Social Adoption of an Invasive Endoscopic Procedure Simulator — Medical Rising STAR® project, an industry-academia collaboration between Denka and Tohoku University —
信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (9th Report) – Status of Lawsuit Seeking Review of Toxicity Assessment of Chloroprene Monomer by EPA –
信息Denka Decides to Invest in Production Capacity Reinforcement of G47Δ, Oncolytic Herpes Simplex Virus Type 1 Product - A Strategic Investment of Approx. 12 Billion Yen to Meet Expected Growth in Demand -
信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (8th Report) – The U.S. Department of Justice (DOJ) files a legal action seeking emission reduction measures from DPE –
IR信息FY2022 Third Quarter Financial Results Presentation Summary of Q&A Session
IR信息FY2022 Third Quarter Financial Results Presentation Materials
IR信息Notice Regarding Personnel Changes in Representative Directors and Executive Officers
IR信息FY2022 Third Quarter Summary of Consolidated Financial Statements
信息Denka Develops “PLATIECO®”, an Eco-friendly Sustainable Plastic — Containing Naturally-derived Eggshell to Contribute to the Reduction of Plastic Use and Greenhouse Gases —
信息U.S. EPA’s Review of the Toxicity Assessment of Chloroprene Monomers (7th Report) – Lawsuit Filed Against EPA for Correction of Toxicity Assessment Based on Latest Science –
IR信息Notice Regarding Revisions to Consolidated Financial Results Forecast and Year-end Dividend Forecast for the Fiscal Year Ending March 31, 2023
信息Notice Regarding End of Commissioned Manufacturing of Macromolecular Sodium Hyaluronate
信息新年贺词
本网站使用Cookie 以确保您舒适地浏览。继续浏览本网站，即表示您同意Cookie的使用。
